• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-Deoxy-D-Glucose (2DG)
      • Acacia Cyanophylla Flower
      • Acori Graminei Rhizoma
      • Aegle Marmelos Correa
      • Agaricus Blazei
      • Aged Garlic Extract
      • Aframomum Melegueta
      • Aloe Arborescens
      • Albizia
      • Alpinia Officinarum
      • Alternanthera Sessilis
      • American Ginseng
      • Amygdalin
      • Anacyclus Pyrethrum
      • Angelica Archangelica
      • Angelica Sinensis
      • Antrodia
      • Artichoke Leaf
      • Artocarpin
      • Ajuga Turkestanica
      • Ashwagandha
      • Aspalathin
      • Astragalus Complanatus
      • Avena Sativa
      • Bacopa Monnieri
      • Bavachin
      • Bee Pollen
      • Betulinic Acid
      • Boswellic Acid
      • Brevilin A
      • Campesterol
      • Casticin
      • Chrysin
      • Cinnamomum Zeylanicum
      • Citrullus Colocynthis
      • Citrus Reticulata Peel
      • Codonopsis
      • Costunolide
      • Cucurbitacin D
      • Daidzein
      • Decursin
      • Delphinidin
      • Digitalis Purprea (Digoxin)
      • Diosmin
      • Embelin
      • Gallic Acid
      • Glycitein
      • Glycyrrhizin
      • Hyperforin
      • Icariin
      • Isorhamnetin
      • Isoorientin
      • Isovitexin
      • Jaceosidin
      • Kaempferol
      • Kurarinone
      • Lemon balm
      • Licoricidin
      • Lipoic acid
      • Lupeol
      • Magnolol
      • Mulberry Leaf
      • Naringenin
      • Nobiletin
      • Oleacein
      • Oleanolic acid
      • Oridonin
      • Parthenolide
      • Phloroglucinol
      • Piceatannol
      • Pristimerin
      • Proanthocyanidins
      • Procyanidin B3
      • Pseudolaric acid b
      • Pterostilbene
      • Rutin
      • Solidago Virgaurea
      • Tangeretin
      • Taraxasterol
      • Trichostatin A
      • Wedelolactone
      • Wogonin
      • Yerba Mate
    • ABOUT
    • SCIENTIFIC STUDIES
      • ALLERGIES & CYTOKINES
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • AMPK
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • APOPTOSIS
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • CARDIAC GLYCOSIDES
      • CENTENARIANS
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • EPIGENETIC MODIFIERS
      • FGF21
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HMGB1
      • HSP90 INHIBITORS
      • HYPERINSULINEMIA
      • IKK
      • IL-6/STAT3
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INSULIN & AGING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LIFESPAN EXTENSION
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MSG (MONOSOSODIUM GLUTAMATE)
      • mTOR: THE RAPID AGING PATHWAY
      • NEUROINFLAMMATION
      • NMDA & ANXIETY & DEPRESSION
      • NOOTROPICS
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PPARY2
      • PREMATURE SENESCENCE
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SIRT1 & LONGEVITY
      • SUGAR & AGING
      • STAT3
      • TELOMERE SHORTENING & PREMATURE AGING
    • HOME
    • FAQ
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    KETOGENIC DIET
    January 15, 2020
    Icariin
    January 16, 2020

    The role of matrix metalloproteinases in aging

    “Proteases are a set of enzymes that have been involved in multiple biological processes throughout evolution. Among them, extracellular matrix (ECM) remodeling has emerged as one of the most relevant functions exerted by these proteins, being essential in the regulation of critical events such as embryonic development or tissue homeostasis. Hence, it is not surprising that dysregulation in any protease function that affects ECM homeostasis may contribute to the aging process. Matrix metalloproteinases (MMPs) are one of the most important families of proteases involved in the tight control of ECM remodeling over time. In this review, we will discuss how MMPs and other proteases alter ECM composition and mechanical properties in aging, thereby affecting stem cell niches and the development of senescent phenotypes. Finally, we will summarize recent findings that associate MMPs with the development of age-related diseases, such as neurodegenerative disorders.”

    SCIENTIFIC STUDIES

    1. Role of matrix metalloproteinases (MMPs) in colorectal cancer
    2. matrix metalloproteinases (MMPs) in oral diseases
    3. matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
    4. The role of matrix metalloproteinases (MMPs) in human caries
    5. matrix metalloproteinases (MMPs): chemical–biological functions and (Q) SARs
    6. matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair
    7. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma
    8. matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases
    9. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva
    10. Proteolytic events of wound-healing—coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules
    11. matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP–dependent and–independent processes
    12. UVA irradiation stimulates the synthesis of various matrix‐metalloproteinases (MMPs) in cultured human fibroblasts
    13. The matrix metalloproteinases (MMPs) in the decidua and fetal membranes
    14. Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs)
    15. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM)
    16. The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?
    17. Expression profile of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in mature human odontoblasts and pulp tissue
    18. Assays of matrix metalloproteinases (MMPs) activities: a review
    19. matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.
    20. Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators
    21. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer
    22. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature
    23. Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs)
    24. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts
    25. matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs
    26. Screening of novel matrix metalloproteinases (MMPs) in human fetal membranes
    27. Multifaceted role of matrix metalloproteinases (MMPs)
    28. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.
    29. Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs)
    30. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans
    31. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis
    32. Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells
    33. matrix metalloproteinases (MMPs) are required for re-epithelialization of cutaneous wounds
    34. Human odontoblast culture method: the expression of collagen and matrix metalloproteinases (MMPs)
    35. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with …
    36. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T‐cell lymphomas
    37. Tumor necrosis factor alpha (TNF-α) coordinately regulates the expression of specific matrix metalloproteinases (MMPs) and angiogenic factors during fracture …
    38. … to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular …
    39. matrix metalloproteinases (MMPs)
    40. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas
    41. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis
    42. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis
    43. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression
    44. Localization of matrix metalloproteinases (MMPs‐2, 8, 9 and 20) in normal and carious dentine
    45. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-β1
    46. Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder.
    47. Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned …
    48. matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine
    49. matrix metalloproteinases (MMPs) safeguard osteoblasts from apoptosis during transdifferentiation into osteocytes: MT1-MMP maintains osteocyte viability
    50. Localization of matrix metalloproteinases,(MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents …
    51. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: A major induction of stromal MMP‐13
    52. Gadolinium chloride reverses dimethylnitrosamine (DMN)-induced rat liver fibrosis with increased matrix metalloproteinases (MMPs) of Kupffer cells
    53. Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis
    54. Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues
    55. Functional role of matrix metalloproteinases (MMPs) in mammary epithelial cell development
    56. Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs)
    57. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and …
    58. Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-induced cardiovascular alterations
    59. Role of matrix metalloproteinases (MMPs) in tumor invasion and metastasis: serial studies on MMPs and TIMPs
    60. Marrow matrix metalloproteinases (MMPs) and tissue inhibitors of MMP in acute leukaemia: potential role of MMP‐9 as a surrogate marker to monitor leukaemic status …
    61. matrix metalloproteinases (MMPs) in the endometrium of bitches
    62. Measurements of several metallic elements and matrix metalloproteinases (MMPs) in saliva from patients with taste disorder
    63. Relaxed specificity of matrix metalloproteinases (MMPs) and TIMP insensitivity of tumor necrosis factor-α (TNF-α) production suggest the major TNF-α converting …
    64. Seesaw of matrix metalloproteinases (MMPs)
    65. Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor
    66. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology
    67. … medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat …
    68. A quantitative gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure …
    69. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated …
    70. Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: correlation of MMP …
    71. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible …
    72. Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability
    73. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis
    74. The activity of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in mammary tumors of dogs and rats
    75. Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis …
    76. Fibrogenesis and carcinogenesis in nonalcoholic steatohepatitis (NASH): involvement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase …
    77. Regulation of matrix metalloproteinases (MMPs) and their inhibitors (TIMPS) during mouse peri-implantation: role of nitric oxide
    78. Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver …
    79. Alcohol Modulation of Cardiac matrix metalloproteinases (MMPs) and Tissue Inhibitors of MMP s Favors Collagen Accumulation
    80. … administration of fucoidan represses cancer metastasis by inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in Lewis tumor …
    81. mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic …
    82. Inhalation of organic dusts and lipopolysaccharide increases gelatinolytic matrix metalloproteinases (MMPs) in the lungs of heaves horses
    83. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the …
    84. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility
    85. Advances in assays of matrix metalloproteinases (MMPs) and their inhibitors
    86. Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves
    87. Infrared optical imaging of matrix metalloproteinases (MMPs) up regulation following ischemia reperfusion is ameliorated by hypothermia
    88. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs)
    89. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion
    90. Assays of matrix metalloproteinases (MMPs) and MMP Inhibitors
    91. Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs)
    92. Role of matrix metalloproteinases (MMPs) and MMP inhibitors on intracranial aneurysms: a review article
    93. matrix metalloproteinases (MMPs): modern molecular markers of open-angle glaucoma diagnosis and therapy
    94. … bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen …
    95. matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: levels of collagenolytic and gelatinolytic MMPs are low …
    96. Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without …
    97. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT) 1-MMP expressions are …
    98. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells
    99. Is the excessive inhibition of matrix metalloproteinases (MMPs) by potent synthetic MMP inhibitors (MMPIs) desirable in periodontitis and other inflammatory diseases …
    100. Urine matrix metalloproteinases (MMPs) as biomarkers for the progression of fracture healing
    101. Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy
    102. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis
    103. Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor–host interaction in a spontaneous metastasis …
    104. matrix metalloproteinases (MMPs) in liver diseases
    105. Comparison of localized versus systemic levels of matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous …
    106. Vectorial release of matrix metalloproteinases (MMPs) from porcine RPE-choroid explants following selective retina therapy (SRT): towards slowing the macular …
    107. matrix metalloproteinases, tissue inhibitors of MMPs and TACE in experimental cerebral malaria
    108. matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
    109. Fisetin protects liver from binge alcohol-induced toxicity by mechanisms including inhibition of matrix metalloproteinases (MMPs) and oxidative stress
    110. matrix metalloproteinases (MMPs) inhibitory effects of an octameric oligopeptide isolated from abalone Haliotis discus hannai
    111. Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression
    112. The expression of matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs) and angiogenesis in relation to the depth of tumor invasion and …
    113. Changes in the concentration of plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients …
    114. Expression and vitamin D-mediated regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy skin and in diabetic …
    115. matrix metalloproteinases (MMPs) are required for wound closure and healing during larval leg regeneration in the flour beetle, Tribolium castaneum
    116. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial …
    117. Dynamic in vivo changes in the activities of gelatinases, matrix metalloproteinases (MMPs), and tissue inhibitor of metalloproteinases (TIMPs) in buffalo (Bubalus …
    118. Effect of taurine chloramine on the production of matrix metalloproteinases (MMPs) in adiponectin-or IL-1β-stimulated fibroblast-like synoviocytes
    119. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1)
    120. Immunohistochemical study of membrane type-matrix metalloproteinases (MT-MMPs) and matrix metalloproteinase-2 (MMP-2) in dermatofibroma and malignant …
    121. Dynamic expression of matrix metalloproteinases (MMP-2,-9 and-14) and the tissue inhibitors of MMPs (TIMP-1,-2 and-3) at the implantation site during tubal …
    122. The role of matrix metalloproteinases (MMPs) and their inhibitors in venous leg ulcer healing
    123. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers
    124. Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3 …
    125. Polydatin alleviates alcohol-induced acute liver injury in mice: Relevance of matrix metalloproteinases (MMPs) and hepatic antioxidants
    126. … , a novel polypeptide in Ciona savignyi, represses angiogenesis via inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs)
    127. Cranberry (Vaccinium macrocarpon) flavonoids inhibit matrix metalloproteinases (MMPs) in human prostate cancer cells
    128. Spatiotemporal expression of matrix metalloproteinases (MMPs) is regulated by the Ca2+-signal transducer S100A4 in the pathogenesis of thoracic aortic …
    129. Molecular biology of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), and the regulation of these genes in tumor tissues
    130. Inhibition of matrix metalloproteinases (MMPs) by tetracyclines
    131. Inhibitory effects of EGb761 on the expression of matrix metalloproteinases (MMPs) and cartilage matrix destruction
    132. Possible role of matrix metalloproteinases (MMPs) in hyperostosis of intracranial meningiomas
    133. Differential activity of matrix metalloproteinases (MMPs) during photoperiod induced uterine regression and recrudescence in Siberian hamsters (Phodopus sungorus …
    134. matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS)
    135. Zinc-binding protein-89 (ZBP-89) cooperates with NF-κB to regulate expression of matrix metalloproteinases (MMPs) in response to inflammatory cytokines
    136. Status of research on matrix metalloproteinases (MMPs) in India
    137. matrix metalloproteinases (MMPs) mediate leukocyte recruitment during the inflammatory phase of zebrafish heart regeneration
    138. matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral …
    139. … (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV …
    140. Elevated levels of matrix metalloproteinases-9 and-1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear …
    141. Blood metal levels and third trimester maternal plasma matrix metalloproteinases (MMPs)
    142. Active site specificity profiling datasets of matrix metalloproteinases (MMPs) 1, 2, 3, 7, 8, 9, 12, 13 and 14
    143. matrix metalloproteinases (MMPs) activity in cultured canine bone marrow stromal cells (BMSCs)
    144. matrix metalloproteinases (MMPs) and trophoblast invasion
    145. Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of …
    146. Kaposi’s sarcoma‐associated herpesvirus (KSHV)‐encoded microRNAs promote matrix metalloproteinases (MMPs) expression and pro‐angiogenic cytokine …
    147. matrix metalloproteinases (MMPs), their genetic variants and miRNA in mitral valve diseases: potential biomarker tools and targets for personalized treatments
    148. Alteration in matrix metalloproteinases (MMPs) activity in fibroblast cell line by dexamethasone: a possible mechanism in corticosteroid-induced glaucoma
    149. Development and validation of novel enzyme activity methods to assess inhibition of matrix metalloproteinases (MMPs) in human serum by antibodies against enzyme …
    150. Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC) …
    151. Evidence for the involvement of matrix-degrading metalloproteinases (MMPs) in atherosclerosis
    152. Inhibition of matrix metalloproteinases (MMPs) in Siberian hamsters impedes photostimulated recrudescence of ovaries
    153. Imaging of atherosclerosis in vivo using a magnetic resonance contrast probe molecularly targeted to matrix metalloproteinases (MMPs)
    154. Phenotype anchoring in zebrafish reveals a potential role for matrix metalloproteinases (MMPs) in tamoxifen’s effects on skin epithelium
    155. Changes of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in the serum of patients with autoimmune diseases: association with …
    156. The role of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in mesangial matrix replacement in AL-amyloidosis (AL-Am): An-vivo …
    157. … Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of matrix metalloproteinases (MMPs) Expression in Periodontal …
    158. Levels of matrix metalloproteinases (MMPs) in tear fluid of mustard gas exposed patients with chronic dry-eye symptoms
    159. Advances in matrix metalloproteinases (MMPs), membrane-type MMPs, and a disintegrin and metalloproteinase and their roles in cellular interaction and migration
    160. Expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) in experimental systems of cartilage matrix degradation
    161. metalloproteinases (MMPs) of the extracellular matrix in dentistry
    162. Role of matrix metalloproteinases (MMPs) in cystic fibrosis
    163. matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs genetic polymorphisms and plasma levels in hypertensive disorders of pregnancy
    164. CD44 up-regulates the expression of matrix metalloproteinases (MMPs) in ovarian and breast carcinoma cells
    165. The Significance of Expression of matrix metalloproteinases (MMPs) in Intimal Hyperplasia after Ballon Injured Rat Aorta
    166. The effects of host derived metalloproteinases on dentin bond and the role of MMPs inhibitors on dentin matrix degradation
    167. matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for …
    168. Dynamics of activities of matrix metalloproteinases-9 and-2, and the tissue inhibitors of MMPs in fetal fluid compartments during gestation and at parturition in the mare
    169. Differential expression of matrix metalloproteinases (MMPs) in lung cancer metastasis
    170. matrix metalloproteinases (MMPs) and Cytokines in Rheumatology
    171. Differential Gene Expression of matrix metalloproteinases (MMPs) in an Oxidative Stress Model of Cataract
    172. Expression of matrix metalloproteinases (MMPs) and Their Natural Tissue Inhibitors (TIMPs) Following Retinal Ischemia-Reperfusion in Rats
    173. Roles of matrix metalloproteinases (MMPs) in SM-induced pathologies
    174. Analysis of matrix metalloproteinases (MMPs) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS)
    175. Expression of matrix metalloproteinases (MMPs) in peptic ulcers and in inflammatory bowel disease
    176. IMPACT OF ALTERED EXPRESSION OF matrix metalloproteinases (MMPs) ON THE DEVELOPMENT AND SEVERITY OF DIABETIC RETINOPATHY.
    177. matrix metalloproteinases (MMPs) ACTIVITY AFTER LIVE DONOR ADULT LIVER TRANSPLANTATION (LDALT).
    178. The Collagenases: Novel Roles for matrix metalloproteinases (MMPs) in Invasion and Metastasis
    179. Characteristic expression of connective tissue components and matrix metalloproteinases (MMPs) during the development of pressure ulcerations
    180. Effect of fucoidan on mRNA and promoter activity of matrix metalloproteinases (MMPs) in skin fibroblasts
    181. Sub-Threshold Q-Switched Laser (Ellex 2RT)-Induced Migration of Human RPE and Concomitant Release of matrix metalloproteinases (MMPs)
    182. The ectoenzyme-side of matrix metalloproteinases (MMPs) makes inflammation by serum amyloid A (SAA) and chemokines go round
    183. Analysis of the polymorphic variants of genes involved in miRNA pathway and its impact on matrix metalloproteinases (MMPs) in pathogenesis of primary open angle …
    184. Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced …
    185. Hypoxia-regulated proteins (HRPs) and matrix metalloproteinases (MMPs) in gastric cancer: impact on malignant progression
    186. The role and control of matrix metalloproteinases (MMPs) in equine cutaneous wounds: a focus on both endogenous and exogenous proteases
    187. Identification and localization of matrix metalloproteinases (MMPs) present within the aqueous humor and iridocorneal drainage angle tissue of normal and …
    188. matrix metalloproteinases-9 (MMPs-9) and-12 are upregulated in the airways of mice with chronic airway inflammation and remodeling
    189. O-126 Expression profiling of matrix metalloproteinases (MMPs) and inhibitors reveals a novel prognostic role for MMP-19 in patients with non-small cell lung …
    190. matrix metalloproteinases (MMPs)
    191. Inhibition of matrix metalloproteinases (MMPs)
    192. Effect of human chorionic gonadotrophin on membrane type matrix metalloproteinases (MT-MMPs) and tissue inhibitors of metalloproteinase (TIMPs) expression in …
    193. matrix metalloproteinases (MMPs) and pancreatic diseases
    194. Matrix-metalloproteinases (MMPS) in Astroglial Cells
    195. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions
    196. matrix metalloproteinases (MMPs) Concentration in Tears of Eyes with Filtering Blebs
    197. SURVEY OF matrix metalloproteinases (MMPs) IN TUMOUR CELLS AND NORMAL FIBROBLASTS
    198. 9. matrix metalloproteinases (MMPs) as Therapeutic Targets
    199. matrix metalloproteinases (MMPs) in Oral Squamous Cell Carcinoma
    200. DEGENERATION OR REMODELLING: matrix metalloproteinases (MMPs) IN THE TORN ROTATOR CUFF
    201. Inhibition of matrix metalloproteinases (MMPs) by tetracyclines
    202. Differential Gene Expression of the matrix metalloproteinases (MMPs) and Their Inhibitors the Tissue Inhibitors of the matrix metalloproteinases (TIMPs) in the Human …
    203. Atherosclerosis, Matrix-metalloproteinases (MMPs) and Ischemia/Hypoxia
    204. matrix metalloproteinases (MMPs) as Cancer Therapeutic Targets
    205. ASTHMATIC PREGNANT FEMALES; EXPRESSION OF matrix metalloproteinases (MMPs).
    206. Program/Abstract# 307 Expression of matrix metalloproteinases (MMPs) during axolotl limb regeneration
    207. Changes in matrix metalloproteinases (MMPs) and Tissue Inhibitors of MMPs Plasma Profiles in Stress-Induced Cardiomyopathy
    208. Peroxynitrite and nitrosative stress in heart failure: Role of matrix metalloproteinases (MMPs) and poly (ADP)-ribose polymerase (PARP)
    209. Mobility of matrix metalloproteinases (MMPs) in the Ageing Human Bruch’s Membrane
    210. CytoskeletonP614Activity and expression profiling of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in the hearts with …
    211. Inhibition of matrix metalloproteinases (MMPs) and invasion of human glioblastoma (U87MG) cells by isoflavones
    212. Roles of matrix metalloproteinases (MMPs) in SM-induced pathologies
    213. Endothelin–1–Mediated Signaling in the Expression of matrix metalloproteinases (MMPs) and Tissue Inhibitors of metalloproteinases (TIMPs) in Astrocytes
    214. Activation of stroma-derived matrix metalloproteinases (MMPs) in a model of gastric cancer.
    215. Assaying endogenous matrix metalloproteinases (MMPs) in acid-etched dentinal cavity walls
    216. 5. matrix metalloproteinases (MMPs) in Homeostasis and Health: Can MMPs be Good for You?
    217. matrix metalloproteinases (MMPs) in patients with pulmonary tuberculosis (PT) and comorbid COPD
    218. Effect of LIF on expression of matrix metalloproteinases (MMPs) in cultured mouse embryo
    219. The role of matrix metalloproteinases (MMPs) and CTNNB1 mutations in endometrial carcinoma
    220. The History of matrix metalloproteinases (MMPs): Milestones, Myths, and (Mis) Perceptions 2
    221. Elevation of IL-1β and matrix metalloproteinases (MMPs) in radiation induced mouse dermatitis and fibrosis.
    222. Immunohistochemical expression of matrix metalloproteinases (MMPs) in rat mammary tumors.
    223. Laser Mediated Activation Of Human Retinal Pigment Epithelial (rpe) Cells And Concomitant Release Of matrix metalloproteinases (MMPs)
    224. Oncostatin M-Mediated Regulation of matrix metalloproteinases and Associated Mediators of MMPs’ Expression in H-ras Transformed Fibroblasts
    225. Atorvastatin, sildenafil and their combination down-regulate matrix metalloproteinases (MMPs) in 2K1C hypertension
    226. Influence of electroporation on matrix metalloproteinases (MMPs) pattern activity in malignant glioma cells propagated ex vivo
    227. The effect of levocarnitine for plasmatic matrix metalloproteinases (MMPs) on acute cerebral infarct patients.
    228. CAN LEVELS OF URINARY matrix metalloproteinases (MMPs) ACT AS AN ALTERNATIVE TO GLEASON’S SCORING IN PROSTATIC …
    229. Expression of membrane-type matrix metalloproteinases (MT-MMPS) in head and neck squamous cell carcinomas, a target for prodrug development
    230. The role of matrix metalloproteinases (MMPs) in pathophysiology of uterine adenomyosis: state of the art.
    231. Oxidative Stress Inactivates the Proteasome and Decreases the Expression of matrix metalloproteinases (MMPs) and Their Inhibitors (TIMPs) in RPE
    232. Plasma matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs and aging and lifelong exercise adaptations in ventricular and arterial stiffness
    233. PGF2-Induced Signaling Mechanisms Involved in the Activation of ERK1/ERK2 and matrix metalloproteinases (MMPs) in Human Ciliary Muscle (HCM) Cells
    234. Brevican is degraded by matrix metalloproteinases (MMPs) and aggrecanase-1 (ADAMTS4) at the different sites
    235. The possible function of matrix metalloproteinases (MMPs) in MSCs differentiation towards the required type of cells.
    236. Bronchoalveolar Lavage (BAL) matrix metalloproteinases (MMPs) from Pulmonary Alveolar Proteinosis Patients (PAP) Processes BAL MCP-3.
    237. Visualizing the Spatial Localization of Active matrix metalloproteinases (MMPs) using MALDI Imaging MS
    238. Regulation of matrix metalloproteinases (MMPs) by ErbB 2 in MCFIOA Human Breast Epithelial Cells
    239. Progesterone and transforming growth factor beta 1 (TGFB1) regulate matrix metalloproteinases (MMPs) in human endometrium
    240. The Role of matrix metalloproteinases (MMPs) and their Proteolytic Degradation of Chemokines in the Lung
    241. Modulation of lung matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) through the GTP-dependent signal transduction pathway
    242. Progesterone and transforming growth factor Beta 1 (tgfβ1) regulate matrix metalloproteinases (MMPs) in human normal endometrium and endometriosis
    243. Active matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are secreted by neural cells in soluble and non soluble forms.
    244. Spatiotemporal Expression Of matrix metalloproteinases (MMPs) Is Regulated By Ca2+-signal Transducer S100a4 In The Thoracic Aortic Aneurysm Pathogenesis
    245. Expression of matrix metalloproteinases (MMPs-2,-7,-9, and-26) and tissue inhibitors of metalloproteinases (TIMPs-1 and-2) in pleomorphic adenomas and adenoid …
    246. Differential gene expression of matrix metalloproteinases (MMPs), MMP inhibitors (TIMPs and RECK), and MMP-activator (EMMPRIN/CD147) during osteogenic …
    247. Migration of Natural Killer Cells. matrix interaction, locomotion and regulation of matrix metalloproteinases (MMPs) by IL-2 and chemokines
    248. Inhibition of matrix metalloproteinases (MMPs) in Siberian Hamsters (Phodopus sungorus) Impedes Photostimulated Recrudescence of Ovaries.
    249. … ) gene expression in meningioma tissue with the expression of matrix metalloproteinases (MMPs)/tissue inhibitors of matrix metalloproteinase (TIMPs) and …
    250. Inhibition of Cold Ischemia and Reperfusion Injury Mediated by matrix metalloproteinases (MMPs) by NFkB Inhibitor PS-341
    251. The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis
    252. The effect of periodontal flap surgery on matrix metalloproteinases (MMPs) and Tissue inhibitors of matrix metalloproteinase-1 (TIMP-1) levels in gingival crevicular …
    253. Transforming growth factor beta 1 (TGFβ1) and progesterone differentially regulate matrix metalloproteinases (MMPs) in human normal endometrium and …
    254. matrix metalloproteinases (MMPs) and acute phase proteins (APP) in predicting the efficacy of intensive phase treatment (IPP) in patients with pulmonary tuberculosis …
    255. Macrophage Insulin-Like Growth Factor I (IGF1) Reduces matrix metalloproteinases (MMPs), Upregulates Atherosclerotic Plaque Collagen and Suppresses …
    256. Using Small Angle X-Ray Scattering (SAXS) to Characterize the Solution Conformation and Flexibility of matrix metalloproteinases (MMPs)
    257. Understanding the Mechanisms Through Which matrix metalloproteinases (MMPs) Contribute to Breast Cancer-Associated Osteolytic Lesions
    258. Differential gene expression of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are modulated during osteogenic/odontogenic differentiation from …
    259. … of matrix metalloproteinases in serum and cerebrospinal-fluid in children with central nervous system infection and relationship between MMPs and impairment of …
    260. The Role of matrix metalloproteinases (MMPs) in Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Loss in Diabetic Retinopathy: In Vivo and in Vitro Studies
    261. Nociceptive Sensory Neurons (NSNs) Promote Alveolar Macrophages'(AMs) Synthesis of matrix metalloproteinases (MMPs) during Cigarette Smoke (CS) via …
    262. Identification of Ocular matrix metalloproteinases (MMPs) Within the Aqueous Humor Outflow Pathway (Trabecular Meshwork and Uveoscleral Tissues) of Normal …
    263. PROLONGED AGGRECANOLYTIC ACTIVATION OF matrix metalloproteinases (MMPs) RELATIVE TO AGGRECANASES IN A RAT TAIL COMPRESSION …
    264. Proteinase-activated receptor (PAR)-2 stimulates cyclooxygenase-2 (COX-2) expression in Caco-2 colon cancer cells: role of matrix metalloproteinases (MMPs)
    265. Effects of choline treatment in concentrations of serum matrix metalloproteinases (MMPs), MMP tissue inhibitors (TIMPs) and immunoglobulins in an experimental …
    266. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression
    267. matrix metalloproteinases (MMPs) generate angiostatin (AS) in vitro and mouse macrophage elastase (MME) is required for growth of metastasis in vivo
    268. … -e2403 Valsartan attenuates pulmonary arterial hypertension via mitogen-activated protein kinases (MAPKs) signal pathway and matrix metalloproteinases (MMPs) in …
    269. Chamazulene reverses osteoarthritic inflammation through regulation of matrix metalloproteinases (MMPs) and NF-kβ pathway in in-vitro and in-vivo models
    270. … C3H Mice Induced by Cigarette Smoke (CS) Demonstrates Pulmonary Inflammation Concomitant With Increased matrix metalloproteinases (MMPs) and Substance P …
    271. Tissue Engineered Vascular Graft Remodelling in a Growing Lamb Model: Expression of matrix metalloproteinases (MMPs) and Collagen Content in vitro and in vivo
    272. Modulation of matrix metalloproteinases (MMPs) and Their Inhibitors (TIMPs) in Neonatal Lung Disorders by Anti-inflammatory Drugs: Potential Role of GTP …
    273. Gonadotropin and Steroid Regulation of matrix metalloproteinases (MMPs) and Their Endogenous Tissue Inhibitors (TIMPs) in the Developed Corpus Luteum …
    274. Differential influence of IL-1-β, TNF-α, and PDGF-BB on the expression of matrix-metalloproteinases (MMPs) and’total’-MMP activity in early-passage RA-and OA …
    275. Expression of membrane-type matrix metalloproteinases (MT-MMPS) during osteoblast differentiation
    276. THE EXPRESSION AND REGULATION OF MEMBRANE-TYPE matrix metalloproteinases (MT-MMPs) IN PROSTATE
    277. INVOLVEMENT OF MEMBRANE-TYPE matrix metalloproteinases (MT-MMPS) IN CAPILLARY TUBE FORMATION BY HUMAN ENDOMETRIAL …
    278. Regulation of membrane type-matrix metalloproteinases (MT-MMPs) in non-malignant and malignant cells
    279. MMPs and Other Matrix-Degrading metalloproteinases in Neurological Disease
    Share
    0
    Interstellar Blend
    Interstellar Blend

    Related posts

    October 6, 2020

    PPARY2


    Read more
    September 16, 2020

    NMDA & ANXIETY & DEPRESSION


    Read more
    September 16, 2020

    INFECTOBESITY


    Read more

    Comments are closed.

    Recent Posts

    • PPARY2
    • NMDA & ANXIETY & DEPRESSION
    • INFECTOBESITY
    • Anti-Acne effect of Flavonoids and Polyphenols
    • NOOTROPICS
    © 2021 Interstellar Blends | Activate Your Super Powers!. © 2019 Interstellar Blends | Activate Your Super Powers!. All Rights Reserved.

    Mandatory FDA Disclaimer
    Privacy Policy
    Terms and Conditions
    Have Questions?
    Contact Gavin Robert McGowen Here

    Join the following facebook groups to learn more:
    Ultimate Weightloss Challenge , Dry Fasting, Longevity Agents , Interstellar Blend Seven Sages, The Infinitely Postive, THE INTERSTELLAR BLEND CHALLENGE: Fluid Restricted Fasting w/ Superherbs

    Love this Website? Contact David Rodriguez to build you one!